Compare IESC & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IESC | DVA |
|---|---|---|
| Founded | 1997 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.1B |
| IPO Year | 1997 | 2002 |
| Metric | IESC | DVA |
|---|---|---|
| Price | $468.48 | $156.48 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $156.75 |
| AVG Volume (30 Days) | 185.2K | ★ 738.3K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.87 | N/A |
| EPS | 4.51 | ★ 9.84 |
| Revenue | $3,371,468,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $22.20 | $3.85 |
| Revenue Next Year | $14.88 | $3.07 |
| P/E Ratio | $110.78 | ★ $15.77 |
| Revenue Growth | ★ 16.89 | 6.46 |
| 52 Week Low | $146.52 | $101.00 |
| 52 Week High | $537.70 | $159.42 |
| Indicator | IESC | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 50.71 | 64.58 |
| Support Level | $353.95 | $146.05 |
| Resistance Level | $485.49 | $158.31 |
| Average True Range (ATR) | 24.89 | 3.93 |
| MACD | 3.70 | -0.50 |
| Stochastic Oscillator | 53.87 | 93.52 |
IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.